Objectives: To explore and compare levels of mental health, care burden, and relationship satisfaction among caregiving spouses of people with mild cognitive impairment or dementia in Parkinson disease (PD-MCI or PDD) or dementia with Lewy bodies (DLB). Methods: Spouses (n ¼ 136) completed measures of mood, stress, resilience, general health, quality of life, care burden, and relationship satisfaction, as well as sociodemographic factors. Additionally, data on motor and neuropsychiatric symptom severity of people with PD-MCI, PDD, or DLB were obtained in a subsample. Results: Most spouses were married women (>85%) who provided a median of 4 years of care and 84 hours of weekly care. Among these, relationship dissatisfaction, stress, anxiety, care burden, and feelings of resentment were common. Spouses of people with PDD and DLB had significantly higher rates of burden, resentment, and depression compared to spouses of people with PD-MCI. Furthermore, unique group differences emerged whereby spouses of people with PDD had significantly longer duration of care provision, higher stress, more relationship dissatisfaction, and fewer positive interactions, compared to PD-MCI group, whereas anxiety and lower levels of mental health were prominent in spouses of people with DLB, compared to PD-MCI group. Despite this, the majority of spouses reported good quality of life, resilience, and satisfaction with the caring role. Conclusion: Both PDD and DLB significantly contribute to poorer mental health and higher levels of care burden in spouses. Clinicians should actively screen the risk of burden, stress, depression, and anxiety among caregiving spouses of people with these conditions.
Introduction
Approximately 10 million people have Parkinson disease (PD) 1 and 47 million people have dementia worldwide, 2 majority of them are cared by spouses and long-term partners. The characteristics of carers of people with PD and non-PD dementias have already been well described. 3 However, there is little understanding of the characteristics of caregiving spouses in the context of mild cognitive impairment, dementia in PD (PD-MCI or PDD), or in dementia with Lewy bodies (DLB). A deeper understanding of the emotional, psychological, and relationship patterns of carers of people with these conditions is crucial so that the care and quality of life of those with PD-MCI, PDD, and DLB can be optimized.
PD is a complex movement disorder, which is characterized by a myriad of motor and nonmotor symptoms, including neuropsychiatric and cognitive abnormalities, autonomic dysfunction, sleep disturbances, and sensory abnormalities. [4] [5] As the motor and nonmotor symptoms are common among people with PD, Langston 6 highlighted that parkinsonism is just "tip of the iceberg" and should rather be seen as the "Parkinson complex". Approximately 25% of people with PD present with MCI at the point of PD diagnosis. 7 Parkinson disease with mild cognitive impairment (PD-MCI) is characterized by impairment in at least 2 cognitive domains, but it is not severe enough to significantly impact the functional ability of an individual. 7 Up to 80% of people develop PDD within 10 to 20 years following the onset of motor symptoms. 8, 9 Dementia in PD is diagnosed when cognitive impairments are severe enough to affect functional ability, and PDD is associated with a significant drop in quality of life, an increase in level of disability, and carer burden. 10 The prevalence of PDD is predicted to rise 3-fold by 2060, 11 underscoring the need to recognize and manage this stage of PD in an optimal way. DLB is the second most common type of dementia 12 and often presents with cognitive changes before, or simultaneously with, typical parkinsonian motor changes. DLB is characterized by fluctuating levels of consciousness, frequent visual hallucinations, and an array of other neuropsychiatric symptoms. 13, 14 PD-MCI, PDD, and DLB are all part of the Lewy body spectrum of disorders, and while PDD and DLB share many underlying pathological changes and certain cognitive and neuropsychiatric features, their course and prognosis may differ. 12, [15] [16] [17] [18] Thus, comparing and contrasting key aspects of these clinical presentations, such as the impact on spousal carers, is important.
PD-MCI, PDD, and DLB are all progressive neurodegenerative conditions characterized by cognitive, neuropsychiatric, and motor changes. As these conditions progress, the support of a carer becomes necessary, and this role is most frequently filled by spouses or life partners, adult children, or other family members. Carers are important in supporting disease management and activities of daily living of people with PD-MCI, PDD, or DLB; however, providing care may lead to challenges in balancing personal and care-related responsibilities and may increase burden and stress. [19] [20] [21] [22] [23] [24] [25] Providing care may also result in depression and anxiety in carers. 22, 26 With the progression of cognitive impairment in PD and DLB, burden 9,23,27-30 and emotional stress [31] [32] [33] intensify in carers, and their quality of life drops. 9, 34 This suggests that the stage of cognitive impairment in the care recipient significantly affects carer well-being. Consequently, caring may lead to neglect of carers' own health and needs, 35, 36 carer burnout, 24 and institutionalization of care recipients, 11, [37] [38] [39] [40] [41] all of which have longterm cost implications.
Studies have explored the impact of PD without cognitive impairment to PD-MCI and PDD 9,34 on carer burden and quality of life, but earlier studies did not include carers of people with DLB. Thus, this current study aimed to describe and compare the sociodemographic and clinical characteristics of caregiving spouses according to the clinical syndrome of care recipients (ie, PD-MCI, PDD, or DLB). We hypothesized that, since the rate of decline and neuropsychiatric burden of people with DLB may be greater than that of people with PD-MCI or PDD, the spouses of people with DLB would experience higher levels of mental health problems, care burden, and relationship dissatisfaction.
Methods

Sample and Setting
This cross-sectional study was nested within the INdiVidualized cognitivE Stimulation Therapy (INVEST) study. The INVEST study is a pilot feasibility randomized controlled trial of individualized cognitive stimulation therapy adapted for people with PD-MCI, PDD, or DLB (CST-PD) and their study partners. 42 Participants were eligible if they were a caregiving spouse of a person with PD-MCI, PDD, or DLB. We applied the term "spouse" in a broad sense to include married partners as well as "life partners" or people who lived with the person with PD-MCI, PDD, or DLB in an intimate way. Individuals who were in a nonintimate relationship with the person with PD-MCI, PDD, or DLB, whose spouse with one of these conditions had died, or who lacked capacity to consent were excluded from the study.
Recruitment and Procedure
We recruited the spouses of people with PD-MCI, PDD, or DLB via 2 routes: (1) baseline assessments in the INVEST study undertaken in a home-based interview between the researcher and the couple (April 2016 to July 2017) and (2) a postal questionnaire for spouses only (July 2017 to January 2018).
In route 1, participant-dyads for the INVEST study were identified through memory or movement disorder clinics in 4 locations in England (Greater Manchester, Derbyshire, North East London, and Warrington). People with PD-MCI, PDD, and DLB were diagnosed by the referring PD specialists who were geriatricians, neurologists, and PD specialist nurses with expertise in the diagnosis and management of PD and working in movement disorder clinics. They all followed accepted diagnostic criteria for possible or probable PD-MCI 43 /PDD 44 and DLB and undertook validated cognitive screening tests (such as the Addenbrooke Cognitive Evaluation rating scale) 45 to ascertain the presence of dementia or MCI. In some cases, neuroimaging (ie, dopamine transporter SPECT imaging or "DaT scan") was used by the referrers to support the diagnosis. Following referral, we screened participants at their first visit using the Montreal Cognitive Assessment (MoCA) 46 to verify and document the extent of cognitive impairment, as well as taking a history to verify the referral diagnosis as PD-MCI, PDD, or DLB.
In route 2, potential participants for the postal questionnaire study were identified through: (a) the "screen-failed" participant list of the INVEST study, who were unable to participate in the INVEST study due to distance from the research centre, high presence of care burden, or lack of interest in participating in an interventional study, and (b) patient databases held by the Greater Manchester Mental Health and North West Boroughs Healthcare National Health Service (NHS) Trusts. In this route, spouses self-reported the diagnosis of the care recipient. As majority of spouses in the postal questionnaire were recruited via the INVEST screen-failed list and NHS patient databases, the diagnosis of care recipients could be verified and it was therefore not considered a major concern of the study. The postal questionnaire, together with an invitation letter, a participant information sheet, a consent form, and a prepaid envelope were posted out to potential participants. We also utilized UK-based charity and research websites (eg, Parkinson UK, Join Dementia Research, the UK Lewy Body Society) as recruitment methods for routes 1 and 2.
The data of 57 spouses were extracted from the INVEST study, which represented all those eligible from this data set. Additionally, 79 spouses participated in the postal questionnaire study. People with PD-MCI, PDD, or DLB did not participate in this study.
Ethics
The INVEST study and the postal questionnaire received ethical approval from the Yorkshire and The Humber-Bradford Leeds Research Ethics Committee (reference number: 15/ YH/0531). All spouses who were eligible to participate in the study provided written informed consent. Additionally, people with PD-MCI, PDD, or DLB recruited via route 1 provided written informed consent through the INVEST study and all had the capacity to consent to participation.
Measures
To gain a comprehensive overview of the emotional, psychological, and relationship factors among caregiving spouses of the 3 groups, we administered a battery of validated rating scales, several of which are novel in this population. The included scales are described below.
Burden, stress, and resilience. The Zarit Burden Interview (ZBI), 47 a 22-item scale, assesses the degree of burden of spouses on a 5-point Likert scale (0 ¼ never to 4 ¼ nearly always). The Relatives' Stress Scale (Rel.SS) 48 consists of 15 items on a 5-point scale from 0 (never/not at all) to 4 (always/ considerably), measuring the amount of stress and upset experienced by the spouse as a result of providing care. The Dyadic Relationship Scale (DRS) 49 assesses positive interaction (6 items) and negative strain (5 items) with the care recipient on a 4-point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree). The Family Caregiving Role (FCR) scale 50 consists of 16 items on a 5-point Likert scale (1 ¼ strongly disagree to 5 ¼ strongly agree), which are divided into 3 subscales: (1) satisfaction with the caring role, (2) resentment, and (3) anger. The Brief Resilience Scale (BRS) 51 explores the ability to bounce back from stress with 6 items on a 5-point Likert scale varying from 1 (strongly disagree) to 5 (strongly agree). Higher scores on the ZBI, Rel.SS, DRS-negative strain, FCR-resentment, and FCR-anger indicate higher levels of burden, stress, strain, and negative feelings, whereas higher scores on DRS-positive interaction, FCR-satisfaction, and BRS show greater positive interaction, satisfaction with the caring role, and higher resilience.
Relationship satisfaction. The Relationship Satisfaction Scale (RSS) 52 explores relationship satisfaction with regard to communication and openness, conflict resolution, degree of affection/caring, intimacy/closeness, and overall satisfaction with the relationship with 7 items on a 7-point Likert scale (0 ¼ very dissatisfied to 6 ¼ very satisfied). Higher score on the RSS indicate higher relationship satisfaction.
Health and quality of life. The Short-Form 12 Health Survey (SF-12) 53 evaluates the physical and mental health of spouses separately in 12 yes/no or Likert-type questions. The Hospital Anxiety and Depression Scale (HADS) 54 consists of 14 items measuring anxiety and depression on a 4-point Likert scale ranging between 0 and 3. The EuroQoL-5D-3L (EQ-5D) 55 assesses health-related quality of life with an index score consisting of 5 indices (ie, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), and a visual analog scale (VAS) rating spouses' health today on a scale between 0% and 100%. Higher scores on the SF-12 and the EQ-5D indicate better physical/mental well-being and quality of life, whereas higher scores on the HADS indicate higher anxiety/ depression.
Parkinson disease-related symptoms (elicited from the home-based assessments in route 1). The Hoehn and Yahr stage (H&Y) 56 (range: I-V) and Unified Parkinson's Disease Rating Scale part III (UPDRS-III) 57 (range: 0-100) measure the severity of care recipients' PD. The Schwab & England Activities of Daily Living scale (SE-ADL) 58 (range: 0%-100%) assesses care recipients' functional ability. The MoCA 46 evaluates the cognitive status of the person with PD-MCI, PDD, or DLB, which can range between 0 and 30, and the Neuropsychiatric Inventory (NPI) 59 measures the frequency and severity of 12 neuropsychiatric symptoms of the care recipients, which were rated by spouses. For H&Y, UPDRS-III, and NPI, higher scores indicate a more advanced disease stage and more frequent and severe neuropsychiatric symptoms.
Demographic information. Age, gender, education, ethnicity, marital status, relationship duration, and living status were collected about both partners. In addition, spouses provided details of diagnosis of care recipients, year of onset of PD or DLB symptoms, and degree of cognitive impairment, as well as regarding spouses' duration of care provision in years and weekly hours.
Several scales of this study, such as the ZBI, Rel.SS, SF-12, EQ-5D, and HADS, have been widely used with carers and spouses of people with PD-MCI, PDD, or DLB; however, the remaining scales (ie, RSS, DRS, BRS, FCR) appear to be novel in this population and their psychometric properties in this sample are described elsewhere (Vatter et al, in submission).
Analyses
Descriptive variables are presented as percentages (categorical variables), mean and standard deviations (SD; normally distributed continuous variables), or medians and interquartile ranges (IQRs; non-normally distributed continuous variables). Parametric tests (ie, t test, analysis of variance [ANOVA]) and nonparametric tests (ie, Spearman correlation coefficient, Mann-Whitney U test, and Kruskal-Wallis H test) were undertaken, as appropriate. Due to the use of several tests and several groups, post hoc tests (ie, Bonferroni, Hochberg, or Games-Howell) were applied. Missing data were imputed with the expectation-maximization method. Outliers were transformed with winsorization, whereby the outliers were assigned the highest or the lowest value found in the sample that was not an outlier. All analyses were conducted in SPSS version 23 and the significance level for the results was set at P < .05.
Results
Sample Characteristics
Participants were spouses of people with PD-MCI, PDD, or DLB (n ¼ 136), all of whom lived together with the care recipient. Most participants (94.9%) were married ( Table 1 ). The median relationship duration was 46.5 years (IQR ¼ 34.75-53.00). The majority of couples comprised a male with PD-MCI, PDD, or DLB and a female spouse (85.3%), and most of them were white British. The mean age of spouses was 69.44 years (SD ¼ 7.62) and that of care recipients was 73.51 years (SD ¼ 6.48). Thirty-seven people had a diagnosis of PD-MCI, 50 had PDD, and 49 had DLB. The median disease duration of PD (including DLB diagnosis in the absence of PD diagnosis) was 5 years (IQR ¼ 3-10) and median duration of cognitive impairment was 4 years (IQR ¼ 2-6). The median duration of PD and cognitive impairment among people with PD-MCI was 6 (IQR ¼ 3.00-7.64) years and 3 (IQR ¼ 1.00-5.00) years, respectively; among people with PDD was 10 (IQR ¼ 5.00-16.25) years and 4.5 (IQR ¼ 2.00-7.25) years, respectively, and among people with DLB was 3 (IQR ¼ 1.00-5.50) years and 4 (IQR ¼ 2.00-6.00) years, respectively. Spouses had provided care for between 0 and 20 years (median ¼ 4; IQR ¼ 2-7) and at the time of the study were providing between 0 and 168 h of care per week (median ¼ 84; IQR ¼ 38.5-168). Nearly half of the spouses (46.0%) provided over 100 hours of care per week. The median care provision duration among spouses of people with PD-MCI was 4 (IQR ¼ 2.00-7.00) years and 56 (IQR ¼ 28.00-168.00) weekly hours, among spouses of people with PDD was 7 (IQR ¼ 3.00, 10.25) years and 126 (IQR ¼ 42.00, 168.00) weekly hours, and among spouses of people with DLB was 2.5 (IQR ¼ 2.00, 6.00) years and 98 (IQR ¼ 42.00, 168.00) weekly hours. In the subsample of care recipients recruited via route 1, 50.9% had an H&Y stage of 2 ( Table 2) . We have outlined the scores of the MoCA, UPDRS-III, SE-ADL, and NPI according to PD-MCI, PDD, or DLB grouping ( Table 2 ). Table 1 presents the spouses' characteristics and Table 3 outlines the cutoff scores of each measure. Tables 4 and 5 report associations among spousal and care recipient variables, respectively, with the Spearman rank correlation analyses (with Bonferroni-adjusted a levels of .003). A separate Spearman rank correlation analysis between the participants recruited via routes 1 and 2 was conducted, which revealed no significant differences; thus, we only present merged data in Table 4 .
Characteristics of Spouses
Burden, stress, and resilience. Nearly 60% of spouses experienced stress (n ¼ 81; Rel.SS) and 36% experienced burden (n ¼ 49; ZBI); however, over 75% of respondents (n ¼ 106) reported good resilience (BRS), highlighting that spouses could adapt well to stressful situations. A large proportion of spouses displayed resentment (n ¼ 85; 62.50%; FCR-resentment) and a smaller proportion of the sample (n Health and quality of life. Clinically significant anxiety and depression was reported by 25.7% (n ¼ 35) and 11.8% (n ¼ 16) of participants, respectively. About half of spouses reported relatively good quality of life according to the EQ-5D-index scores (n ¼ 67, 49.3%) and VAS (n ¼ 71, 52.2%). Lower spouses' mental health (SF-12) was related to intrapersonal aspects (ie, own anxiety, depression, quality of life, resilience) and interpersonal aspects (ie, burden, stress, strain, resentment, and anger related to care provision).
Parkinson disease symptoms. For the subsample of 57 spouses and people with PD-MCI, PDD, or DLB, Spearman rank correlation analyses were performed using a Bonferroni-adjusted a level of .005 (.05/10). The duration of caregiving years correlated with care recipients' PD and cognitive impairment duration (both P < .001), H&Y stage (P ¼ .001), SE-ADL (P < .001), and weekly care provision hours (P ¼ .002), but not with UPDRDS-III (P ¼ .109) ( Table 4 ). There was also a significant negative association between weekly care provision hours and SE-ADL (P < .001), but this was not related to PD motor symptom severity.
Group Comparisons
We conducted 2 sets of group comparisons: (1) a pooled analysis with 136 life partners, which is presented below, and (2) separate analyses with participants recruited via route 1 (n ¼ 57 spouses) and route 2 (n ¼ 79), which is available as a supplementary file. Burden, stress, and resilience. A 1-way ANOVA revealed that spouses of people with PDD and DLB experienced more burden and resentment than spouses of people with PD-MCI (both P < .05; Table 6 ). In addition, spouses of people with PDD experienced higher stress levels (P ¼ .019) and less positive interaction with the care recipient (P ¼ .018) compared to spouses of people with PD-MCI, but these variables did not differ between DLB and PD-MCI groups. The FCRsatisfaction subscale failed the assumptions of ANOVA; thus, we applied a Kruskal-Wallis H test, which revealed no statistical differences between the disease groups (P > .05).
Weekly care provision hours did not differ among PD-MCI, PDD and DLB groups (P > .05); however, when PD-MCI was compared with the 2 dementia groups combined, spouses of people with PDD and DLB devoted more hours to caregiving each week (m ¼ 102. 59 Relationship satisfaction. Spouses of people with PDD had lower relationship satisfaction (P ¼ .047) than spouses of people with PD-MCI, but we did not observe any statistically significant difference in relationship satisfaction between the PD-MCI and DLB groups.
Health and quality of life. Spouses of people with DLB had higher levels of anxiety (P ¼ .010) and lower levels of mental health (P ¼ .024) than spouses of people with PD-MCI, but no difference was found between PDD and PD-MCI groups on these variables. Using a 1-way ANOVA, we found a statistically significant difference in the HADS-depression scores among spouses of people with PD-MCI, PDD, or DLB, F(2,133) ¼ 9.94, P < .001. Spouses of people with PDD and DLB had significantly higher depression scores than those caring for people with PD-MCI (both P < .001). Finally, we found no statistically significant differences between PDD and DLB groups on any of the variables examined (P > .05).
Discussion
Our study demonstrated that burden, stress, relationship dissatisfaction, and feelings of resentment are common among spouses of people with PD-MCI, PDD, or DLB. We also found that spouses of people with PDD and DLB have higher rates of burden, depression, and feelings of resentment, compared to spouses of people with PD-MCI. Furthermore, spouses of people with PDD report higher levels of stress and lower levels of relationship satisfaction, whereas spouses of people with DLB exhibit higher levels of anxiety and lower levels of mental health, in comparison to PD-MCI. The daily care provision hours exceeded 14 hours for over half of spouses in this study, which is significantly higher than the level found in carers of people with dementia (ie, between 3 and 11 h/day). 60 These findings highlight the complexity of PD-related dementias as well as an immense commitment by carers in taking care of their relatives. Several findings resonate with previous studies in terms of high levels of burden and stress, 9, 23, 24, 31, 61 but relationship dissatisfaction, perceived negative feelings (resentment), and resilience are new findings emerging from this study, despite being well-researched constructs in carers of people with non-PD type dementia. [62] [63] [64] [65] [66] This could be explained by a number of reasons. First, people with PD-MCI, PDD, or DLB have higher rates of burden, 30,67 stress, 32,33 depression, 68 lower ability to live well, 69 and more tension and arguments in the dyadic relationship 70 compared to carers of people with Alzheimer disease and/or vascular dementia. Second, most carers are older adults themselves and many have physical or mental health problems, 2 which makes caring for a relative increasingly demanding while also taking care of oneself. Third, the new findings in regard to relationship dissatisfaction, feelings of resentment, and resilience in this study could be explained by the use of the scales (ie, RSS, FCR, and BRS, respectively), which were generic, condition-neutral, and which have not been used in this population before. For this reason, we undertook psychometric property testing of these scales, which would act as a guidance to future studies in regard to selecting an appropriate measure in this population (reported by Vatter et al, in submission). Furthermore, the constructs of relationship satisfaction and resilience are both multifaceted, complex, and lack clear definitions, which add additional complexities into the measurement process. Future studies should focus on examining the constituent parts, either through factors derived from a factor/cluster analysis of the measurements or develop validated condition-specific scales de novo.
Notwithstanding the high prevalence of burden, stress, and low levels of mental health, many spouses in the current study had good quality of life and resilience, emphasizing their ability to cope and adjust to the challenging nature of the care recipients' condition. These findings are consistent with a recent qualitative study of spouses of people with PD-MCI, PDD, or DLB 71 where spouses had learned to accept and adapt to their partners' condition despite the demands and stresses they faced. Importantly, however, in this study, female spouses reported that they cherished their marital vows and exhibited commitment to support their partners "in health and in sickness". 71 Care provision frequently takes place within a long-term intimate relationship, and having a good relationship quality is important as it can protect against stressors and support carers' quality of life 32, 72 ; therefore, strengthening and supporting interpersonal relationships are crucial and should be a focus of future studies.
The finding that spouses of people with DLB had high levels of anxiety and poor mental health is novel despite comparative studies demonstrating that these carers have significantly more burden 30 and stress 32, 33 compared to carers of people with other types of dementia. The impact of DLB on spouses may be more profound as the speed of onset of the condition is faster, the intensity of symptoms and levels of fluctuation are often higher, and impairments in certain areas of cognitive functioning greater than in PDD. 73, 74 Interestingly, our study found that burden, stress, resilience, relationship satisfaction, quality of life, anxiety, depression, and mental health levels did not differ between spouses of people with PDD and DLB. These findings suggest that both PDD and DLB appear to have a similar effect on spouses, which could be due to the 2 syndromes having a clinically similar symptom presentation in terms of cognitive, psychiatric, and motor symptoms as well as share underlying pathology. 11, [13] [14] [15] [16] [17] [18] However, further studies are required to determine the impact of PDD and DLB on spouses.
The limitations of the study should be acknowledged. We were unable to elicit the disease-specific aspects, such as motor, psychiatric, and cognitive symptoms of PD for all care recipients due to the nature of the postal questionnaire, which precluded a wider exploration of the impact of disease-specific aspects on spouses. We were also not able to capture spouses' health history and these data could have expanded our knowledge regarding the role that their physical and mental health needs played in their ability to provide care to their relatives. We also acknowledge the 2 different modes of administering the questionnaires as the data were combined from participants recruited through the INVEST study, where a researcher was present to help with any queries, and the postal questionnaire study, where participants self-completed the measures. This may have influenced our results to a small extent. Furthermore, participants in the postal questionnaire had a self-selection bias as they chose whether to take part in the study or not. This bias would not have been as marked had we recruited all participants through a single route. Finally, all information provided by spouses was subjective in nature and could have been biased or over-/underestimated depending on how spouses felt at the time of the assessments. Applying a longitudinal design could potentially extend our knowledge regarding spousal characteristics.
Conclusion
This is the first and largest study to date describing and comparing the characteristics of spouses of people with PD-MCI, PDD, or DLB. Importantly, our study highlighted that spouses of people with PDD and DLB have high rates of burden, stress, relationship dissatisfaction, and resentment as well as poor levels of mental health. A diagnosis of PDD and DLB should alert the clinician to the risk of carer burden, strain and stress, and clinical symptoms, such as depression and anxiety, which will have implications for patient outcomes.
